Article info

Download PDFPDF

Trabectedin plus PLD versus PLD monotherapy in patients with platinum-sensitive relapsed ovarian cancer: a cost-effectiveness analysis in Spain

Authors

  1. Correspondence to Itziar Oyagüez Pharmacoeconomics & Outcomes Research Iberia, C/de la Golondrina 40A, Madrid 28023, Spain; ioyaguez{at}porib.com
View Full Text

Citation

Montalar J, Cajaraville G, Carreras M, et al
Trabectedin plus PLD versus PLD monotherapy in patients with platinum-sensitive relapsed ovarian cancer: a cost-effectiveness analysis in Spain

Publication history

  • Received April 18, 2012
  • Accepted May 22, 2012
  • First published June 20, 2012.
Online issue publication 
August 30, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.